AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other Vaccines & Immune Therapies by Quarter
Other Vaccines & Immune Therapies — Established RoW product sales ($M) ($M)
AstraZeneca Other Vaccines & Immune Therapies: $4M in Q2 2026. That is the highest of the 10 quarters on record here.
Where the Q2 2026 figure comes from
“|| Other ID | | 34 | | ( 31 ) | | ( 34 ) | | ( 1 ) | | 73 | | 30 | | ( 20 ) | | ( 26 ) | | 1 | | 78 | | 69 | | 4 | | ( 68 ) | | ( 66 )”
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Vaccines & Immune Therapies — Established RoW product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 4 | – | Form 6-K FY2026Q2 Earnings Release ↗ |
| Q1 2026 | Mar 31, 2026 | 3 | – | Form 6-K FY2026Q1 Earnings Release ↗ |
| Q4 2025 | Dec 31, 2025 | 0 | – | Form 6-K FY2025Q4 Earnings Release ↗ |
| Q3 2025 | Sep 30, 2025 | 0 | – | Form 6-K FY2025Q3 Earnings Release ↗ |
| Q2 2025 | Jun 30, 2025 | 0 | – | Form 6-K FY2025Q2 Earnings Release ↗ |
| Q1 2025 | Mar 31, 2025 | 0 | – | Form 6-K FY2025Q1 Earnings Release ↗ |
| Q4 2024 | Dec 31, 2024 | 0 | – | Form 6-K FY2024Q4 Earnings Release ↗ |
| Q3 2024 | Sep 30, 2024 | 0 | – | Form 6-K FY2024Q3 Earnings Release ↗ |
| Q2 2024 | Jun 30, 2024 | 0 | – | Form 6-K FY2024Q2 Earnings Release ↗ |
| Q1 2024 | Mar 31, 2024 | 0 | – | Form 6-K FY2024Q1 Earnings Release ↗ |
Breakdown
What makes up other Vaccines & Immune Therapies
Cite this data
StockData. (2026). AstraZeneca Other Vaccines & Immune Therapies ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-vi-erow
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.